In light of the limited availability of effective antiviral drugs for CNS infections and the scarcity of targeted treatments for neurodegenerative diseases, this study aimed to investigate the potential of the antibiotic ceftriaxone to manipulate GLT-1 expression and thus prevent neurodegeneration following viral infection. The gene discussed is SLC1A2; the disease is viral infectious disease.